Review decisions

Showing 210 results of 291 total
Summary Safety Review - INTUNIV XR (guanfacine hydrochloride) - Assessing the Potential Risk of Raynaud's Phenomenon
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00111
Issued / Original Publication Date: 2016-08-15
Summary Safety Review - Trifecta Heart Valve - Assessing the Potential Risk of Early Wear
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00112
Issued / Original Publication Date: 2016-08-15
Summary Safety Review - Antidepressants - Assessing the Potential Risk of Serious Eye Disorder (Angle-Closure Glaucoma)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00113
Issued / Original Publication Date: 2016-08-12
Summary Safety Review - Hormone Replacement Therapy (Estrogenic and Progestogenic Agents) and Selective Estrogen Receptor Modulators (SERMs) - Assessing the Potential Risk of Ovarian Cancer
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00114
Issued / Original Publication Date: 2016-08-09
Summary Safety Review - Propecia (finasteride 1 mg) and Proscar (finasteride 5 mg) - Assessing the Potential Risk of Seizures
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00115
Issued / Original Publication Date: 2016-08-05
Summary Safety Review - ENBREL (etanercept) - Assessing the potential harm to the developing babies of mothers treated with ENBREL
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00098
Issued / Original Publication Date: 2016-08-04
Summary Safety Review - YONDELIS (trabectedin) - Assessing the Potential Risk of Fluid Leakage from Small Blood Vessels (capillary leak syndrome)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00102
Issued / Original Publication Date: 2016-08-04
Summary Safety Review - Codeine-containing products - Further Assessing the Risk of Serious Breathing Problems in Children and Adolescents
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00096
Issued / Original Publication Date: 2016-07-28
Summary Safety Review - Hydrocodone-containing products - Assessing the Risk of Serious Breathing Problems (respiratory depression) in Children and Adolescents
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00100
Issued / Original Publication Date: 2016-07-28
Summary Safety Review - KOGENATE FS/HELIXATE FS (Antihemophilic Factor [Recombinant]) - Assessing the Potential Changes in the Known Risk of Inhibitors (Inhibitory Antibody - IA) Development in Previously Untreated Patients with Severe Hemophilia A
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00116
Issued / Original Publication Date: 2016-07-26

Displaying 201 - 210 of 291 | Page 21 of 30
Report a problem or mistake on this page
Please select all that apply:
Date modified: